Study of Velcade and Thalidomide in Patients With Myelodysplasia

Clinical trial NCT00271804 · TERMINATED

Trial details

NCT number: NCT00271804
Sponsor: Massachusetts General Hospital
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2005-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.